Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
3Daughters develops a frameless, non-hormonal intrauterine contraceptive device (IUD) designed to reduce insertion pain and improve the user experience for women. The company is preparing clinical trials for its magnetic IUD platform and exploring applications in targeted uterine drug delivery.
0 investors
4D Path develops a cancer diagnostics technology that combines statistical physics with cancer biology to quantify cell cycle deregulations and tumor dynamics, generating indices that predict individual patient response to therapy. It works with cancer researchers and biopharma companies to guide personalized treatment selection and support drug discovery and development.
0 investors
0 investors
0 investors
507 Capital is a real estate investment firm that acquires and manages value-add retail shopping centers in the Midwest, generating returns through leasing vacant spaces and optimizing property operations. The firm targets triple-net lease retail properties and aims to deliver annual distributions of 6-10% with annualized returns of 16-20% upon exit.
0 investors
0 investors
0 investors
60 Degrees Pharmaceuticals develops treatments and preventive medicines for vector-borne diseases such as babesiosis and malaria. Founded in 2010, the company focuses on tick-borne and parasitic infections affecting patients and travelers globally.
0 investors
0 investors
0 investors
7 Hills Pharma is a clinical-stage drug development company developing first-in-class integrin-targeted agonists intended to improve the effectiveness of cancer immunotherapies and stem cell transplantation. Its lead molecules, Alintegimod and 7HP935, target solid tumors, hematological malignancies, and CD34+ cell-based therapies.
0 investors
0 investors
A28 Therapeutics develops a targeted oncolytic peptide platform for treating multiple cancer types, with its lead candidate AT-101 in late-stage development for metastatic ovarian cancer with liver metastases and hepatocellular carcinoma. The company is also exploring combinations of AT-101 with immuno-oncology drugs and chemotherapy.
0 investors
0 investors
0 investors
0 investors
0 investors
AbbVie develops and sells biopharmaceutical therapies across immunology, neuroscience, oncology, and aesthetics, addressing autoimmune diseases, neurologic conditions, blood cancers, and cosmetic applications through products like Skyrizi, Rinvoq, Humira, Vraylar, Imbruvica, and Botox.
0 investors
0 investors
0 investors
0 investors
0 investors